Samsara BioCapital, L.P. 13D and 13G filings for Chinook Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-11-22 4:15 pm Sale | 2023-08-11 | 13D | Chinook Therapeutics, Inc. KDNY | Samsara BioCapital, L.P. | 0 0.000% | -5,181,557 (Position Closed) | Filing |
| 2022-06-01 4:00 pm Purchase | 2020-10-05 | 13D | Chinook Therapeutics, Inc. KDNY | Samsara BioCapital, L.P. | 5,181,557 8.400% | 5,181,557 (New Position) | Filing |